Expanded Hemodialysis Therapy Market - Regional Analysis
North American Market Insights
North America industry is expected to hold largest revenue share of 35% by 2035. The growth of the market can be attributed majorly to the rising healthcare expenditure, growing disposable income, and rising demand for the development of new products. All these factors are expected to propel the adoption rate of expanded hemodialysis therapy in the upcoming years. The national health expenditure of the U.S. in 2020, rose by 9.7% and reached USD 4.1 trillion, or USD 12,350 for every person, as per the CMS. Further, the availability of a strong healthcare network in the region, coupled with the availability of supportive policies by the governing bodies that promote the market players to opt for investing in more research works to bring up more feasible solutions so as to develop efficient expanded hemodialysis therapy options are also anticipated to contribute to market growth in the region.
APAC Market Insights
The Asia Pacific expanded hemodialysis therapy market, amongst the market in all the other regions, is projected to hold the second largest share of about 28% during the forecast period. Rapid growth in the geriatric population who are more prone to kidney disorders along with the rising prevalence of chronic diseases among the people living in the Asia Pacific region is considered to be a major factor for market growth during the analysis period. Furthermore, the constant support by the regulatory bodies and major key players in the region is also considered to positively contribute to market growth in the region in the next few years. Also, the presence of major key players along with the availability of effective diagnostic imaging services for diagnosing underlying kidney problems in the region is estimated to projected to create a positive outlook for market growth during the forecast period.
Europe Market Insights
Further, the market in Europe, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. One of the main factors that are attributed to propel the growth of the market is the availability of a large pool of patients in the region with chronic kidney disease, kidney stones, and other kidney-related disorders which needs to be treated with expanded hemodialysis therapy. In addition to the aforementioned factor, also the rapid rise of awareness about kidney disease and its treatment is anticipated to increase the opportunities for the utilization of expanded hemodialysis therapy.
